Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayMar 13, 2018 3:30 pm

American Vanguard Corp. (NYSE: AVD) Starts Presentation at 30th Annual ROTH Conference

American Vanguard (NYSE: AVD) is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. The company employs a strategy of acquiring or licensing both new and well-established product lines that serve numerous high valued market niches. New product development and international expansion also provide an additional stimulus for growth. For more information, visit the company’s website at www.american-vanguard.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach…

Continue Reading

TuesdayMar 13, 2018 3:30 pm

Depomed, Inc. (NASDAQ: DEPO) Starts Presentation at 30th Annual ROTH Conference

Depomed (NASDAQ: DEPO) is a specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors through commercializing innovative products for pain and neurology related disorders. Depomed currently markets three medicines focused on neuropathic pain and migraine through its neurology and pain businesses. The company’s emerging specialty business is focused on orphan drug indications and areas of unmet medical need. Depomed is headquartered in Newark, California. For more information, visit the company’s website at www.depomed.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of…

Continue Reading

TuesdayMar 13, 2018 3:30 pm

Fusion Telecommunications International, Inc. (NASDAQ: FSNN) Starts Presentation at 30th Annual ROTH Conference

Fusion (NASDAQ: FSNN), a provider of integrated cloud solutions to small, medium and large businesses, is the industry's single source for the cloud. Fusion's advanced, proprietary cloud service platform enables the integration of leading edge solutions in the cloud, including cloud communications, contact center, cloud connectivity and cloud computing. Fusion's innovative, yet proven cloud solutions lower the customers' cost of ownership, and deliver new levels of security, flexibility, scalability and speed of deployment. For more information, visit the company’s website at www.fusionconnect.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a…

Continue Reading

TuesdayMar 13, 2018 3:30 pm

Acme United Corp. (NYSE: ACU) Starts Presentation at 30th Annual ROTH Conference

Acme United (NYSE: ACU) is a worldwide supplier of innovative cutting, measuring first aid and sharpening products to the school, home, office, sporting goods, hardware and industrial markets. Its brands include Westcott®, Clauss®, Camillus®, Cuda®, PhysiciansCare®, First Aid Only®, Pac-Kit®, DMT® and Spill Magic®.  The company’s operations are in the United States, Canada, Europe (located in Germany) and Asia (located in Hong Kong and China.) For more information, visit the company’s website at www.acmeunited.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all…

Continue Reading

TuesdayMar 13, 2018 3:30 pm

Energous Corp. (NASDAQ: WATT) Starts Presentation at 30th Annual ROTH Conference

Energous (NASDAQ: WATT) is the developer of WattUp®, an award-winning, wire-free charging technology aimed to renew the way consumers and industries charge and power electronic devices at home, in the office, in the car and beyond. WattUp is a radio frequency (“RF”) based charging solution that delivers intelligent, scalable power via radio bands, similar to a Wi-Fi router. WattUp differs from older wireless charging systems in that it delivers contained power, at a distance, to multiple devices — thus resulting in a wire-free experience that saves users from having to remember to plug in their devices. For more information, visit…

Continue Reading

TuesdayMar 13, 2018 3:30 pm

Synthesis Energy Systems, Inc. (NASDAQ: SES) Starts Presentation at 30th Annual ROTH Conference

Synthesis Energy Systems (NASDAQ: SES) is a global provider of clean, high-value energy generated from low-cost and low-grade coal, biomass and municipal solid waste—produced through a proprietary technology for converting these resources into a clean synthesis gas (syngas) and methane. The company’s proprietary technology replaces costly natural gas-based energy, facilitating the production of clean, low-cost power; industrial fuel gas; chemicals; fertilizers; transportation fuels; and substitute natural gas. The company’s technology can further produce high-purity hydrogen for cleaner transportation fuels. SES enables greater fuel flexibility for both large-scale and efficient small- to medium-scale operations that are close to fuel sources. For…

Continue Reading

TuesdayMar 13, 2018 3:30 pm

S&W Seed Co (NASDAQ: SANW) Starts Presentation at 30th Annual ROTH Conference

S&W Seed Company (NASDAQ: SANW) is a global agricultural company headquartered in Sacramento, California. S&W’s vision is to be the world’s preferred proprietary seed company which supplies a range of forage and specialty crop products that supports the growing global demand for animal proteins and healthier consumer diets. S&W is a global leader in alfalfa seed, with significant research and development, production and distribution capabilities. S&W sells its seed products in more than 30 countries around the globe. S&W also provides hybrid sorghum and sunflower, and is utilizing its research and breeding expertise to develop and produce stevia, the all-natural,…

Continue Reading

TuesdayMar 13, 2018 3:30 pm

Medigene AG (MDGEF) Starts Presentation at 30th Annual ROTH Conference

Medigene (OTC: MDGEF) is a biotechnology company headquartered in Martinsried near Munich, Germany. The company is focused on developing highly innovative, complementary treatment platforms to target various types and stages of cancer with a special concentration on the development of personalized T cell-based immunotherapies. The company currently has various drug candidates in clinical and pre-clinical development. For more information, visit the company’s website at www.medigene.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective…

Continue Reading

TuesdayMar 13, 2018 3:23 pm

Earth Science Tech, Inc. (ETST): Transparency, Scientific Research and Future Products

Received grant from Government of Québec through Canno Inno Laboratories subsidiary Canna Inno Laboratories enhances collaboration between the company’s resources in Canada and the U.S. while providing access to grants Sound scientific research and transparent studies Earth Science Tech, Inc. (OTC: ETST), a Florida-based biotechnology company focused on cannabis, industrial hemp and cannabinoid research and development for nutraceuticals, pharmaceuticals and medical devices, announced last week that its subsidiary, Canna Inno Laboratories Inc., has received a grant from the Government of Québec for innovation in the pharmaceutical industry. ETST plans to apply for additional funding under Canada’s Scientific Research and Experimental…

Continue Reading

TuesdayMar 13, 2018 3:00 pm

Recro Pharma, Inc. (NASDAQ: REPH) Starts Presentation at 30th Annual ROTH Conference

Recro Pharma (NASDAQ: REPH) is a revenue-generating specialty pharmaceutical company focused on therapeutics for hospitals and other acute care settings. The company operates through two business divisions: an acute care, hospital product division and a revenue-generating contract development and manufacturing, or CDMO, division. The company’s lead product candidate is a proprietary injectable form of meloxicam, which is a long-acting preferential COX-2 inhibitor. Since injectable meloxicam is in the non-opioid drug class, Recro Pharma believes it will overcome many of the issues that are associated with commonly prescribed opioid therapeutics, such as respiratory depression, constipation, excessive nausea and vomiting. It also…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000